Home
>
Biofil Chemicals Pharmaceuticals Ltd Financials

Biofil Chemicals Pharmaceuticals Ltd Financial Statement

Biofil Chemicals Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Dec 2023	Sep 2023	Jun 2023
Revenue	5.06	17.4	2.46
Operating Expense	4.84	17.13	2.02
Net Profit	0.09	0.12	0.24
Net Profit Margin	1.78	0.69	9.76
Earning Per Share	0.06	0.08	0.15
EBIDTA	0.22	0.27	0.44
Effective Tax Rate	9.09	11.11	18.18

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

5.06

4.84

0.09

1.78

0.06

0.22

9.09

17.4

17.13

0.12

0.69

0.08

0.27

11.11

2.46

2.02

0.24

9.76

0.15

0.44

18.18

Biofil Chemicals Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	30.04	22.38	35.75
Operating Expenses Annual	28.87	21.05	34.15
Operating Profit Annual	1.26	1.48	2.4
Interest Annual	0.04	0.04	0.07
Depreciation	0.43	0.43	0.41
Net Profit Annual	0.56	0.7	1.24
Tax Annual	0.23	0.32	0.68

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

30.04

28.87

1.26

0.04

0.43

0.56

0.23

22.38

21.05

1.48

0.04

0.43

0.7

0.32

35.75

34.15

2.4

0.07

0.41

1.24

0.68

Biofil Chemicals Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	0.14	0.44	0.26
Cash Flow from Operations	-0.11	-0.22	1.11
Cash Flow from Investing	-0.01	-0.07	-0.1
Cash Flow from Financing	0.02	-0.01	-0.83
Cash Flow at the End	0.04	0.14	0.44

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

0.14

-0.11

-0.01

0.02

0.04

0.44

-0.22

-0.07

-0.01

0.14

0.26

1.11

-0.1

-0.83

0.44

Biofil Chemicals Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	4.19	6.61	6.71
PBIT Margin (%)	2.76	4.69	5.57
PBT Margin (%)	-66.31	-113.72	-73.95
Net PROFIT Margin (%)	1.86	3.13	3.47
Return On Networth / Equity (%)	1.12	1.4	2.49
Return On Networth /Employed(%)	1.65	2.11	3.92
Return On Assets (%)	3.19	4.13	7.6
Total Debt / Equity(X)	0.03	0.03	0.05
Asset Turnover Ratio (%)	1.71	1.32	2.19

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

4.19

2.76

-66.31

1.86

1.12

1.65

3.19

0.03

1.71

6.61

4.69

-113.72

3.13

1.4

2.11

4.13

0.03

1.32

6.71

5.57

-73.95

3.47

2.49

3.92

7.6

0.05

2.19

Biofil Chemicals Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	9	9.42	9.78
Total Current Assets Annual	22.41	9.31	23.46
Non Current Assets Annual	9	9.42	9.78
Total Shareholders Funds Annual	17.3	16.84	16.13
Total Assets Annual	31.41	18.73	33.24

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

22.41

17.3

31.41

9.42

9.31

9.42

16.84

18.73

9.78

23.46

9.78

16.13

33.24

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Biofil Chemicals Pharmaceuticals Ltd Financial Statement

Open Demat Account

Dividend Pages

PE Ratio